HIV resistance monitoring plays an important role in maintaining effective HIV treatment. It helps healthcare professionals identify changes in the virus that may reduce the effectiveness of antiretroviral medications. Monitoring resistance can support informed treatment decisions, especially when viral suppression becomes difficult to achieve. Understanding how resistance develops, when testing may be recommended.
HIV resistance monitoring involves evaluating whether changes in the human immunodeficiency virus affect its response to antiretroviral therapy (ART). HIV can multiply rapidly and produce genetic variations. Some variations may allow the virus to continue replicating even when a person is taking prescribed medications. These changes are known as drug resistance.
Antiretroviral medications work by targeting different stages of the HIV life cycle. When the virus develops mutations that interfere with these medications, treatment may become less effective. Resistance monitoring helps healthcare professionals understand whether particular medications remain suitable for an individual's treatment plan.
Drug resistance can develop for several reasons, including inconsistent medication use, previous treatment exposure, and the presence of resistant HIV strains at the time of infection. However, resistance does not develop in every person receiving HIV treatment.
Important aspects of HIV resistance monitoring include:
Identifying mutations: Detecting genetic changes in HIV that may affect medication effectiveness.
Evaluating treatment response: Understanding whether prescribed antiretroviral medications are controlling viral replication.
Supporting treatment decisions: Helping healthcare professionals select appropriate medication combinations.
Recognizing treatment challenges: Investigating possible resistance when viral suppression is not achieved or maintained.
Improving long-term management: Supporting continued evaluation of treatment effectiveness.
Resistance monitoring is particularly relevant when viral load increases despite treatment or when treatment failure is suspected.
Healthcare professionals use different resistance testing methods to identify mutations that may influence HIV treatment. The selection of a test depends on an individual's treatment history, viral load, and clinical circumstances.
Genotypic resistance testing is commonly used to identify genetic mutations associated with resistance to specific antiretroviral medications. It examines the genetic material of HIV and compares identified mutations with established resistance information.
Phenotypic resistance testing evaluates how effectively HIV grows in the presence of different antiretroviral medications under laboratory conditions. It helps determine which medications may have reduced activity against the virus. This approach can be useful in certain complex treatment situations.
Resistance testing is not necessarily required at every routine appointment. Healthcare professionals generally recommend it according to treatment history, clinical findings, and applicable HIV treatment guidelines.
Important considerations in resistance testing include:
Before starting treatment: Testing may help identify transmitted drug resistance and guide initial medication selection.
During suspected treatment failure: Resistance testing can help investigate why viral suppression is not being maintained.
After previous treatment exposure: Earlier medication use may influence the likelihood of developing resistance.
During treatment changes: Results can provide information when healthcare professionals consider alternative medication combinations.
Following clinical evaluation: Test findings should be interpreted alongside viral load measurements and treatment history.
Resistance monitoring is one component of comprehensive HIV care. Viral load testing remains essential for assessing how well treatment controls the virus, while CD4 testing provides information about immune system function. Together, these assessments help healthcare professionals evaluate treatment response and make clinically informed decisions about ongoing HIV management.